SCOPUS 정보 검색 플랫폼 - 논문 보기

메뉴 건너뛰기

Journal of Controlled Release

Volumn 72, Issue 1-3, 2001, Pages 217-224

Improvements in protein PEGylation: Pegylated interferons for treatment of hepatitis C

(2) Kozlowski, Antoni a Milton Harris, J a

a Shearwater Corporation (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; MACROGOL; REAGENT;

ARTICLE; CHEMISTRY; CONTROLLED STUDY; DRUG SAFETY; HEPATITIS C; HUMAN; MOLECULAR WEIGHT; PRIORITY JOURNAL;

ANIMALS; HEPATITIS C; HUMANS; INTERFERONS; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS;

EID: 0035858379 PISSN: 01683659 EISSN: None Source Type: Journal
DOI: 10.1016/S0168-3659(01)00277-2 Document Type: Article

Times cited : (179)

References (39)

1
- 0034651580
- Pathogenesis, natural history, treatment and prevention of hepatitis C
- (2000) Ann. Intern. Med. , vol.132 , pp. 296-305
- Liang, J.T.¹ Rehermann, B.² Seeff, L.B.³ Hoofnagle, J.H.⁴

2
- 0032547938
- Interferon α-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
- (1998) New England J. Med. , vol.339 , pp. 1485-1492
- McHutchison, J.G.¹ Gordon, S.C.² Schiff, E.R.³

3
- 0003472956
- ACS Books, Washington, DC
- (1997) Poly(ethyleneglycol): Chemistry and Biological Applications
- Harris, J.M.¹ Zalipsky, S.²

4
- 0040688671
- A double-blind, multicenter, randomized, parallel dose-comparison study of six regimens of 5 kD, linear peginterferon α-2a compared with roferon-a in patients with chronic hepatitis c
- Maui, Hawaii
- (1999) International Conference on Therapies for Viral Hepatitis: December 6th
- O'Brien, C.¹ Pockros, P.² Reddy, R.³

5
- 33749155445
- Pharmacological properties of five polyethylene glycol conjugates of interferon α-2a
- Maui, Hawaii
- (1999) International Conference on Therapies for Viral Hepatitis: December 6th
- Bailon, P.¹ Spence, C.² Schaffer, C.A.³

6
- 0000211888
- A controlled, randomized, multicenter ascending dose phase II trail of pegylated interferon α-2a (PEG) vs. standard interferon α-2a (IFNα) for treatment of chronic hepatitis C
- (1999) Gastroenterology , vol.116 , Issue.2 , pp. 1275
- Shiffman, M.¹ Pockros, P.J.² Reddy, R.K.³

7
- 4243339996
- A dose-ranging study of PEG-Intron and ribavirin in chronic hepatitis C - Safety, efficacy, and virological rationale
- (1999) Hepatology , vol.30 , Issue.2
- Glue, P.¹ Fang, J.² Sabo, R.³

8
- 0000553168
- PEG-interferon-α2b: Pharmacokinetics, pharmacodynamics, safety and preliminary efficacy data
- (1999) Hepatology , vol.30 , Issue.2
- Glue, P.¹ Rouzier-Panis, R.² Raffanel, C.³

9
- 0003472957
- Plenum, New York
- (1992) Polyethylene Glycol Chemistry. Biotechnical and Biomedical Applications
- Harris, J.M.¹

10
- 0026124772
- The therapeutic value of poly(ethylene glycol)-modified proteins
- (1991) Adv. Drug Deliv. Rev. , vol.6 , pp. 133-151
- Nucci, M.L.¹ Shorr, R.² Abuchowski, A.³

11
- 0026438972
- The uses and properties of PEG-linked proteins
- (1992) Crit. Rev. Ther. Drug Carrier Syst. , vol.9 , pp. 249-304
- Delgado, D.¹ Francis, G.E.² Fisher, D.³

12
- 0347170869
- Safety of poly(ethyleneglycol) and poly(ethylene glycol) derivatives
- J.M. Harris, S. Zalipsky (Eds.), ACS Books, Washington, DC
- (1997) Poly(ethyleneglycol): Chemistry and Biological Applications , pp. 45-57
- Working, P.K.¹ Newman, M.S.² Johnson, J.³

13
- 0021246228
- Polyethyleneglycol reactive antibodies in man: Titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors
- (1984) Int. Arch. Allergy Appl. Immunol. , vol.74 , pp. 36-39
- Richter, A.W.¹ Akerblom, E.²

14
- 0033136959
- Accelerated clearance of polyethylene glycol-modified proteins by antipolyethylene glycol IgM
- (1999) Bioconj. Chem. , vol.10 , pp. 520-528
- Cheng, T.L.¹ Wu, P.Y.² Wu, M.F.³

15
- 0028337034
- Distribution and tissue uptake of poly(ethyleneglycol) with different molecular weights after intravenous administration to mice
- (1994) J. Pharm. Sci. , vol.83 , pp. 601-606
- Yamaoka, T.¹ Tabata, Y.² Ikada, Y.³

16
- 0009971781
- Biochemistry and immunology of poly(ethyleneglycol)-modified adenosine deaminase (PEG-ADA)
- J.M. Harris, S. Zalipsky (Eds.), ACS Books, Washington, DC
- (1997) Poly(ethyleneglycol): Chemistry and Biological Applications , pp. 134-144
- Hershfield, M.S.¹

17
- 0029167706
- A branched monomethoxypoly(ethyleneglycol) for protein modification
- (1995) Bioconj. Chem. , vol.6 , pp. 62-69
- Monfardini, C.¹ Schiavon, O.² Caliceti, P.³

18
- 0033167240
- Biopharmaceutical properties of uricase conjugated to neutral and amphiphilic polymers
- (1999) Bioconj. Chem. , vol.10 , pp. 638-646
- Caliceti, P.¹ Schiavon, O.² Veronese, F.M.³

19
- 0346540569
- Preparation and characterization of poly(ethyleneglycol)ylated human growth hormone antagonist
- J.M. Harris, S. Zalipsky (Eds.), ACS Books, Washington, DC
- (1997) Poly(ethyleneglycol): Chemistry and Biological Applications , pp. 170-181
- Olson, K.¹ Gehant, R.² Mukku, V.³

20
- 0024558259
- Effects of coupling chemistry on activity of a polyethyleneglycol-modified enzyme
- (1989) J. Bioact. Comp. Polym. , vol.4 , pp. 17-24
- Yoshinaga, Y.¹ Harris, J.M.²

21
- 0025701741
- Proton NMR characterization of polyethylene glycols and derivatives
- (1990) Macromolecules , vol.23 , pp. 3742-3746
- Dust, J.M.¹ Fang, Z.H.² Harris, J.M.³

22
- 0021248339
- Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-asparaginase conjugates
- (1984) Cancer Biochem. Biophys. , vol.7 , pp. 175-186
- Abuchowski, A.¹ Kazo, G.M.² Verhoest, C.R.³

23
- 0022113126
- Synthesis of polyethylene glycol derivatives
- (1985) J. Macromol. Sci.-Rev. Macromol. Chem. Phys. , vol.C25 , pp. 325-373
- Harris, J.M.¹

24
- 0026812687
- Evaluation of a new reagent for covalent attachment of polyethylene glycol to proteins
- (1992) Biotechnol. Appl. Biochem. , vol.15 , pp. 100-114
- Zalipsky, S.¹ Seltzer, R.² Meron-Rudolph, S.³

25
- 0004313366
- US Pat. 5,951,974, September 14, 1999
- Interferon polymer conjugates
- Gilbert Park, C.W.¹ Cho, M.²

26
- 0002871098
- Alkyl succinimidyl carbonates undergo Lossen rearrangement in basic buffers
- (1998) Chem. Commun. , pp. 69-70
- Zalipsky, S.¹

27
- 0029759584
- Characterization and stability of N-terminally PEGylated rhG-CSF
- (1996) Pharm. Res. , vol.13 , Issue.7 , pp. 996-1002
- Kinstler, O.B.¹ Brems, D.N.² Lauren, S.L.³

28
- 0032725837
- Pegylated recombinant human soluble tumor necrosis factor receptor type I (rHu-sTNF-RI): A novel high-affinity TNF receptor designed for chronic inflammatory diseases
- (1999) Ann. Rheum. Dis. , vol.58 , Issue.S1
- Edwards, C.K.¹

29
- 0030135376
- Preparation and characterization of poly(ethyleneglycol) vinylsulfone
- (1996) Bioconj. Chem. , vol.7 , pp. 363-368
- Morpurgo, M.¹ Veronese, F.M.² Kachensky, D.³ Harris, J.M.⁴

30
- 33749909387
- W.O. 99/55377
- Polyol-IFN-β conjugates
- El Tayar, N.¹ Roberts, M.J.² Harris, J.M.³ Sawlivich, W.⁴

31
- 0003472958
- US Pat. 5,672,662, September 30, 1997
- Polyethyleneglycol and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
- Harris, J.M.¹ Kozlowski, A.²

32
- 0032868653
- Therapeutic antibody fragments with prolonged in vivo half-lives
- (1999) Nature Biotechnol. , vol.17 , pp. 780-783
- Chapman, A.P.¹ Antoniw, P.² Spitali, M.³

33
- 0004327044
- P.C.T. US99/23536: October 8
- (1999) Heterobifunctional poly(ethyleneglycol) derivatives and methods for their preparation
- Bentley, M.D.¹ Harris, J.M.² Kozlowski, A.³

34
- 0035086519
- Rational design of a potent, long-lasting form of interferon: A 40 kDa branched polyethylene glycol-conjugated interferon α-2a for the treatment of hepatitis C
- (2001) Bioconjugate Chem. , vol.12 , pp. 195-202
- Bailon, P.¹ Palleroni, A.² Schaffer, C.A.³ Spence, C.L.⁴ Fung, W.-J.⁵ Porter, J.E.⁶ Erlich, G.K.⁷ Pen, W.⁸ Xu, Z.-X.⁹ Modi, M.W.¹⁰ Farid, A.¹¹ Berthold, W.¹² Graves, M.¹³

35
- 0001299981
- A branched methoxy 40 kDa polyethyeneglycol (PEG) moiety optimizes the pharmacokinetics (PK) of PEG-interferon α2a (PEG-IFN) and may explain its enhanced efficacy in chronic hepatitis C (CHC)
- (1999) Hepatology , vol.40 , Issue.SUPPL.
- Algranati, N.E.¹ Sy, S.² Modi, M.³

36
- 0003246250
- Evaluation of the safety and efficacy of once-weekly peginterferon α-2a (PEGASYS™) for chronic hepatitis C: A multinational, randomized study
- May 1-4, Rotterdam, The Netherlands
- (2000) The European Association for the Study of the Liver
- Zeuzem, S.¹ Feinman, S.V.² Rasenack, J.³

37
- 0000030786
- Multinational evaluation of the efficacy and safety of once-weekly PEG-interferon α-2A (PEG-IFN) in patients with chronic hepatitis C (CHC) with compensation cirrhosis
- (1999) Hepatology , vol.30 , Issue.SUPPL.
- Heathcote, E.J.¹ Shiffman, M.L.² Cooksley, G.³

38
- 0032585237
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
- (1998) Lancet , vol.352 , pp. 1426-1432
- Poynard, T.¹ Marcellin, P.² Lee, S.S.³

39
- 0000030258
- Combination therapy with peginterferon α-2a (PEG-IFN) and ribavirin in the treatment of patients with chronic hepatitis C (CHC): A phase II open-label study
- (1999) Hepatology , vol.30 , Issue.4 PART 2
- Sulkowski, M.¹ Reindollar, R.² Yu, J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.